243 related articles for article (PubMed ID: 20303372)
61. Oral Uncaria rhynchophylla (UR) reduces kainic acid-induced epileptic seizures and neuronal death accompanied by attenuating glial cell proliferation and S100B proteins in rats.
Lin YW; Hsieh CL
J Ethnopharmacol; 2011 May; 135(2):313-20. PubMed ID: 21402140
[TBL] [Abstract][Full Text] [Related]
62. Remodeling of extracellular matrix and epileptogenesis.
Dityatev A
Epilepsia; 2010 Jul; 51 Suppl 3():61-5. PubMed ID: 20618403
[TBL] [Abstract][Full Text] [Related]
63. Axon initial segment structural plasticity in animal models of genetic and acquired epilepsy.
Harty RC; Kim TH; Thomas EA; Cardamone L; Jones NC; Petrou S; Wimmer VC
Epilepsy Res; 2013 Aug; 105(3):272-9. PubMed ID: 23602553
[TBL] [Abstract][Full Text] [Related]
64. Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Verslegers M; Lemmens K; Van Hove I; Moons L
Prog Neurobiol; 2013 Jun; 105():60-78. PubMed ID: 23567503
[TBL] [Abstract][Full Text] [Related]
65. The prevention of behavioral consequences of idiopathic generalized epilepsy: evidence from rodent models.
van Luijtelaar G
Neurosci Lett; 2011 Jun; 497(3):177-84. PubMed ID: 21354267
[TBL] [Abstract][Full Text] [Related]
66. Beta-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity.
Michaluk P; Kolodziej L; Mioduszewska B; Wilczynski GM; Dzwonek J; Jaworski J; Gorecki DC; Ottersen OP; Kaczmarek L
J Biol Chem; 2007 Jun; 282(22):16036-41. PubMed ID: 17426029
[TBL] [Abstract][Full Text] [Related]
67. Matrix metalloproteinase 9 and epileptogenesis - the crucial role of the enzyme and strategies to prevent the disease development.
Khomiak D; Kaczmarek L
Postepy Biochem; 2018 Oct; 64(3):222-230. PubMed ID: 30656907
[TBL] [Abstract][Full Text] [Related]
68. Orexins increase penicillin-induced epileptic activity.
Kortunay S; Erken HA; Erken G; Genç O; Sahiner M; Turgut S; Turgut G
Peptides; 2012 Apr; 34(2):419-22. PubMed ID: 22394654
[TBL] [Abstract][Full Text] [Related]
69. Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation.
Castardeli E; Duarte DR; Minicucci MF; Azevedo PS; Matsubara BB; Matsubara LS; Campana AO; Paiva SA; Zornoff LA
Eur J Heart Fail; 2007 Nov; 9(11):1081-5. PubMed ID: 17921050
[TBL] [Abstract][Full Text] [Related]
70. The role of matrix metalloproteinase-9 in negative reinforcement learning and plasticity in alcohol dependence.
Go BS; Sirohi S; Walker BM
Addict Biol; 2020 Mar; 25(2):e12715. PubMed ID: 30648329
[TBL] [Abstract][Full Text] [Related]
71. Decreased ERp57 Expression in WAG/Rij Rats Thalamus and Cortex: Possible Correlation with Absence Epilepsy.
Sahin D; Karadenizli S; Kasap M; Oztas B; Kir HM; Akpinar G; Ates N
Protein Pept Lett; 2018; 25(4):398-404. PubMed ID: 29412101
[TBL] [Abstract][Full Text] [Related]
72. MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury.
Warren KM; Reeves TM; Phillips LL
J Neurotrauma; 2012 Jul; 29(10):1922-40. PubMed ID: 22489706
[TBL] [Abstract][Full Text] [Related]
73. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy.
Vafadari B; Salamian A; Kaczmarek L
J Neurochem; 2016 Oct; 139 Suppl 2():91-114. PubMed ID: 26525923
[TBL] [Abstract][Full Text] [Related]
74. Synaptic plasticity mediating cocaine relapse requires matrix metalloproteinases.
Smith AC; Kupchik YM; Scofield MD; Gipson CD; Wiggins A; Thomas CA; Kalivas PW
Nat Neurosci; 2014 Dec; 17(12):1655-7. PubMed ID: 25326689
[TBL] [Abstract][Full Text] [Related]
75. Nidogen and nidogen-associated basement membrane proteins and neuronal plasticity.
Köhling R; Nischt R; Vasudevan A; Ho M; Weiergräber M; Schneider T; Smyth N
Neurodegener Dis; 2006; 3(1-2):56-61. PubMed ID: 16909038
[TBL] [Abstract][Full Text] [Related]
76. Morphometric changes and molecular mechanisms in rat models of idiopathic generalized epilepsy with absence seizures.
Jones NC; O'Brien TJ; Powell KL
Neurosci Lett; 2011 Jun; 497(3):185-93. PubMed ID: 21354269
[TBL] [Abstract][Full Text] [Related]
77. Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy.
Rempe RG; Hartz AMS; Soldner ELB; Sokola BS; Alluri SR; Abner EL; Kryscio RJ; Pekcec A; Schlichtiger J; Bauer B
J Neurosci; 2018 May; 38(18):4301-4315. PubMed ID: 29632167
[TBL] [Abstract][Full Text] [Related]
78. Early postnatal expression and localization of matrix metalloproteinases-2 and -9 during establishment of rat hippocampal synaptic circuitry.
Aujla PK; Huntley GW
J Comp Neurol; 2014 Apr; 522(6):1249-63. PubMed ID: 24114974
[TBL] [Abstract][Full Text] [Related]
79. The extracellular matrix glycoprotein tenascin-C and matrix metalloproteinases modify cerebellar structural plasticity by exposure to an enriched environment.
Stamenkovic V; Stamenkovic S; Jaworski T; Gawlak M; Jovanovic M; Jakovcevski I; Wilczynski GM; Kaczmarek L; Schachner M; Radenovic L; Andjus PR
Brain Struct Funct; 2017 Jan; 222(1):393-415. PubMed ID: 27089885
[TBL] [Abstract][Full Text] [Related]
80. Mitochondrial dysfunction in epilepsy.
Folbergrová J; Kunz WS
Mitochondrion; 2012 Jan; 12(1):35-40. PubMed ID: 21530687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
